{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:51:09Z","timestamp":1782489069536,"version":"3.54.5"},"reference-count":11,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,3,12]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Narcolepsy is a rare disorder of central hypersomnolence which is often under-recognised owing to a variable clinical phenotype. Narcolepsy type 1 (NT1) is caused by loss of hypothalamic hypocretin (orexin) secreting neurons, which function to maintain wakefulness. There is strong evidence that NT1 is an immune-mediated disorder associated with the class II human leucocyte antigen DQB1*06:02 allele. Immune checkpoint inhibitors have revolutionised the treatment of many cancers; however, through their mechanism of action, they are associated with immune-related adverse effects. We describe a complex case of NT1 following ipilimumab and nivolumab exposure for management of metastatic melanoma.<\/jats:p>","DOI":"10.1136\/bcr-2026-272044","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:10:12Z","timestamp":1775484612000},"page":"e272044","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Narcolepsy type 1 following immune checkpoint inhibitor therapy for metastatic melanoma"],"prefix":"10.1136","volume":"19","author":[{"given":"Aiden","family":"Cushnahan","sequence":"first","affiliation":[{"name":"Respiratory and Sleep Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Hii","sequence":"additional","affiliation":[{"name":"Respiratory and Sleep Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Kee","sequence":"additional","affiliation":[{"name":"Respiratory and Sleep Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia"},{"name":"Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Rees","sequence":"additional","affiliation":[{"name":"Respiratory and Sleep Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia"},{"name":"University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wallbridge","sequence":"additional","affiliation":[{"name":"Respiratory and Sleep Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"2026062608153465000_19.4.e272044.1","doi-asserted-by":"crossref","unstructured":"Tai JE , Sivam S , D\u2019Rozario A , et al . Central disorders of hypersomnolence - A narrative review on current and potential biomarkers. Sleep Med Rev 2025;84. doi:10.1016\/j.smrv.2025.102167","DOI":"10.1016\/j.smrv.2025.102167"},{"key":"2026062608153465000_19.4.e272044.2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41577-023-00902-9","article-title":"The immunopathogenesis of narcolepsy type 1","volume":"24","author":"Liblau","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"2026062608153465000_19.4.e272044.3","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8482"},{"key":"2026062608153465000_19.4.e272044.4","doi-asserted-by":"crossref","unstructured":"Meng L , Wu H , Wu J , et al . Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks. Cell Death Dis 2024;15. doi:10.1038\/s41419-023-06389-5","DOI":"10.1038\/s41419-023-06389-5"},{"key":"2026062608153465000_19.4.e272044.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"2026062608153465000_19.4.e272044.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2025-335998"},{"key":"2026062608153465000_19.4.e272044.7","doi-asserted-by":"crossref","unstructured":"Natori Y , Sasaki E , Soeda S , et al . Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab. J Immunother Cancer 2020;8. doi:10.1136\/jitc-2020-001164","DOI":"10.1136\/jitc-2020-001164"},{"key":"2026062608153465000_19.4.e272044.8","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.5664\/jcsm.9328","article-title":"Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline","volume":"17","author":"Maski","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"2026062608153465000_19.4.e272044.9","doi-asserted-by":"crossref","unstructured":"Kim M , Kizilbash SH , Laramy JK , et al . Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine. Pharm Res 2018;35. doi:10.1007\/s11095-018-2455-9","DOI":"10.1007\/s11095-018-2455-9"},{"key":"2026062608153465000_19.4.e272044.10","doi-asserted-by":"crossref","unstructured":"Yoshida-Tanaka K , Shimada M , Honda Y , et al . Narcolepsy type I-associated DNA methylation and gene expression changes in the human leukocyte antigen region. Sci Rep 2023;13. doi:10.1038\/s41598-023-37511-4","DOI":"10.1038\/s41598-023-37511-4"},{"key":"2026062608153465000_19.4.e272044.11","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2024-004327"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2026-272044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:19:58Z","timestamp":1782487198000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2026-272044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":11,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,6]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bcr-2026-272044"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2026-272044","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}